LEOLIN

This brand name is authorized in Nigeria.

Active ingredients

The drug LEOLIN contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5381	Tablet	LEOLIN TABLETS TAB 500 mg 2 X 7	128 RNW-PP-168148 LEOLIN TABLETS LEVOFLOXACIN 500 MG Each film coated tablet contains: Levofloxacin Hemihydrates Eqv. to Levofloxacin USP .. 500 mg, Excipients.. Maize Starch BP, Lactose BP, PVPK- 30 BP, Purified Water BP, Purified Talc BP, Magnesium Stearate BP. Aerosol 200 BP, Sodium Starch glycolate BP, Microcrystalline Cellulose BP B4-5381 Drugs Imported Products 2x7 Prescription Only Medicine (POM) 9/29/2020 ASSURA PHARMACEUTICAL AND HEALTH PRODUCTS LTD, BORNO WAY, ADEKUNLE JUNCTION, EBUTE METTA LAGOS 80385597 assurapharmaltd@yahoo.com BAADER SCHULZ LABORATORIES, PLOT NO. J-6, OIDC, M.G. UDYOG NAGAR, DAHBEL, NANI DAMAN-396 210. INDIA, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5381